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Abstract Despite their high sequence homology, the peptide 
neurotoxins ¢o-conotoxin MVIIA and MVIIC selectively block 
N- and P/Q-type calcium channels, respectively. To study the 
recognition mechanism of calcium channel subtypes, two 
chimeric analogs of ¢o-conotoxin MVIIA and MVIIC were 
synthesized by exchanging their N- and C-terminal halves. 
Binding assay for both N- and P/Q-type calcium channels 
showed that amino acid residues restricted to the N-terminal half 
are important for the recognition of N-type channels, whereas 
essential residues for P/Q-type channel recognition are widely 
spread over the whole ¢o-conotoxin molecule. 
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1. Introduction 
Voltage-gated calcium channels play crucial roles in regu- 
lating intracellular calcium concentrations in a wide variety of 
cells, and are classified into several subtypes according to their 
electrophysiological nd pharmacological properties [1-3]. 
Among them, N- and P/Q-type channels are essential for 
the regulation of neurotransmitter release from a wide variety 
of neurons. Various specific ligands have been used to distin- 
guish the subtypes of calcium channels pharmacologically. ~0- 
Conotoxins form a large family of peptide neurotoxins iso- 
lated from the venom of marine Conus snails. N-type calcium 
channels are blocked by to-conotoxin GVIA (coGVIA) and 
MVI IA  (coMVIIA), and P/Q-type channels by co-conotoxin 
MVI IC (o~MVIIC) [4]. 
Although o)GVIA is most widely used as a standard phar- 
macological tool to identify the N-type channel, the amino 
acid sequence of coMVIIC is much more similar to that of 
~oMVIIA than to that of coGVIA. Therefore, in order to study 
in detail the structural differences that determine toxin selec- 
tivity for N- and P/Q-type calcium channels, coMVIIA is the 
most appropriate representative of the N-type calcium chan- 
nel blockers. 
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In the present study, we synthesized two chimeric analogs 
of toMVIIA and toMVIIC, namely A-C and C-A, which have 
the N-terminal half of coMVIIA and the C-terminal half of 
toMVIIC, and vice versa, respectively, in order to search 
broadly for the residues essential for the recognition of cal- 
cium channel subtypes (Fig. 1). Binding assays for both N- 
and P/Q-type channels uggested that the amino acid residues 
in the N-terminal half are important for the recognition of N- 
type channels, whereas essential residues for the P/Q-type rec- 
ognition are widely spread over the whole e0MVIIC molecule. 
2. Materials and methods 
2.1. Materiab 
Fmoc-amino acids and other reagents used on the synthesizer were 
obtained from Applied Biosystems Japan (Chiba, Japan). Fmoc-NH- 
SAL-resin was obtained from Watanabe Chemical Industries Ltd. 
(Hiroshima, Japan). Other reagents for peptide synthesis were ob- 
tained from Peptide Institute (Osaka, Japan) or Kokusan Chemical 
Works Ltd. (Tokyo, Japan). Lysyl endopeptidase and thermolysin 
were purchased from Wako Pure Chemicals Ltd. (Osaka, Japan). 
2.2. Peptide synthesis 
Solid phase peptide synthesis was conducted on an Applied Bio- 
systems 431A peptide synthesizer. Amino acid analyses were per- 
formed on a Beckman System Gold amino acid analyzer after hydrol- 
ysis in 6 M hydrochloric acid at 110°C for 24 h and derivatization by 
4-dimethylaminoazobenzene-4'-sulfonyl chloride. MALDI-TOF-MS 
was measured on a PerSeptive Biosystems Voyager Linear mass spec- 
trometer by using ct-cyano-4-hydroxy-cinnamic cid as a matrix. An- 
alytical HPLC was conducted on a Shimadzu LC-6A system with 
ODS column (4.6×250 mm). Preparative HPLC was performed 
with a Shimadzu LC-8A system with ODS column (20 × 250 mm). 
All the analogs were synthesized by a similar procedure as described 
previously for the synthesis of coMVIIC and its analog [5]. Briefly, 
linear precursors of 0~-conotoxin analogs were synthesized by solid 
phase methodology of Fmoc chemistry. After trifluoroacetic acid 
cleavage, crude linear peptide was diluted to a final peptide concen- 
tration of 0.05 mM and subjected to oxidative disulfide bond forma- 
tion at 4°C for 3 5 days in 1 M ammonium acetate buffer (pH 7.8) 
containing reduced/oxidized glutathione (molar ratio of pep- 
tide:GSH:GSSG was 1:100:10). The folding reaction was monitored 
by HPLC and stopped by lowering the pH of the solution to 34  with 
AcOH. The crude cyclic products were purified by successive chroma- 
tographies with Sephadex G-50F, CM-cellulose CM-52, and prepara- 
tive HPLC with an ODS column. The structure and purity of syn- 
thetic peptide were confirmed by analytical HPLC, amino acid 
analysis, and MALDI-TOF-MS measurements. 
2.3. Enzymatic digestion for the determination of disulfide bond 
combination 
To a solution of synthetic peptide (0.4 mg) in 100 ktl of 0.1 mM 
phosphate buffer (pH 6.5) was added a solution of lysyl endopeptidase 
(10 ~g) in 20 btl of the same buffer. The mixture was incubated at 37°C 
for 1.5 h and subjected to HPLC separation and MALDI-TOF-MS 
measurements. The major fragment was lyophilized and dissolved into 
0.4 ml of 0.1 M ammonium formate buffer (pH 6.5). To 100 ~1 of this 
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K. Sato et aL/FEBS Letters 414 (1997) 480-484 481 
, t I ,  I I 
CKGKGA/PLG_JRKTIMYDCC TIGSCI-LRJSGLG__~-NH2 C-A 
5 10 15 20 25 
Fig. l. Amino acid sequences and disulfide bonds of mMV[IA, 
mMVIIC, and their chimeric analogs. 
solution were added a solution of thermolysin (20 p.g) in 20 ~tl of the 
same buffer and 80 ~tl of CaC12 solution (2.5 mM in the same buffer). 
The mixture was incubated at 37°C for 3 h and subjected to HPLC 
separation and MALDI-TOF-MS measurements. 
2.4. CD measurements 
CD spectra were recorded on a JASCO J-600 spectropolarimeter in 
H20 solution (0.01 M sodium phosphate, pH 7.0) at 20°C, using a 
quartz cell of 1 mm path length. The spectra are expressed as molar 
ellipticity [0]. 
3.2. DLrulfide bond combination 
According to the method as described for coMVIIC by 
Kubo et al. [7], we successively digested coMVIIC, A-C, and 
C-A with lysyl endopeptidase and thermolysin. First digestion 
with lysyl endopeptidase gave a single major component with 
MH + 2618 for coMVIIC, 2346 for A-C, and 2505 for C-A, 
indicating that the C-termini of Lys residues were selectively 
hydrolyzed. After a second digestion with thermolysin, HPLC 
of the reaction solution showed one major peak and a few 
minor peaks (Fig. 3). Compounds from peaks IA -3A showed 
the same MH ÷ 869 by MALDI -TOF-MS analysis and those 
from peaks 1B, 2B, and 3B gave 1537, 1270, and 1424, re- 
spectively. The structures of these fragments are summarized 
in Fig. 4. Isocratic elution on reversed phase HPLC of IA 3A 
showed the same retention time both in co-injection and in- 
dividual injection (data not shown), indicating that A-C and 
C-A have the same disulfide bond combination as that of 
native coMVIIC. 
2.5. Binding assay 
Rat cerebellar P2 membranes (10 I.tg) in 0.1 ml of 25 mM Tris, 150 
mM NaC1, 0.1% bovine serum albumin adjusted to pH 7.4 with HCI 
(TBSA) were incubated with 0.5 nM [125I]mGVIA or [125I]mMVIIC 
for 1 h at 30°C. Membrane-bound radioactivity was measured after 
rapid filtration and washing on GF/C (Whatman) filters treated with 
0.3% polyethyleneimine as described previously [6]. 
3. Results 
3.1. Synthesis of peptides 
We synthesized two chimeric analogs of mMVIIA and 
e0MVIIC, namely A-C and C-A, which have the N-terminal 
half of mMVIIA and the C-terminal half of c0MVIIC, and 
vice versa, respectively (Fig. 1). Linear precursors of A-C 
and C-A prepared by solid phase methodology were subjected 
directly to an oxidative folding reaction (disulfide bond for- 
mation), since these crude products showed high purity by 
HPLC analysis (Fig. 2). After 3 days reaction, the HPLC 
profile of the reaction solution became constant and showed 
one major component and several minor peaks. These major 
products were purified until they migrated as a single peak on 
an analytical HPLC. 
3.3. CD spectra 
CD spectra of A-C and C-A were measured and compared 
to those of mMVIIA and mMVIIC (Fig. 5) [8]. CD spectral 
profiles seemed to be related to the number of amino acid 
residues. Both 25-mer peptides, mMVIIA and C-A, showed 
similar CD profiles to each other with positive Cotton effects 
around 245 nm and negative ones around 205 nm. In contrast, 
peptides with 26 residues, mMVIIC and A-C, showed positive 
Cotton effects around 230 nm and negative ones around 203 
nm. These results suggest hat the chain length between filth 
and sixth Cys residues is reflected in the difference in CD 
spectra. 
3.4. Biological activity 
Dose-inhibition curves of chimeric analogs on the binding 
of [12~I]mGV1A and [lZSI]mMVIIC to rat cerebellar P2 mem- 
branes were compared to those of coMVIIA and mMVIIC 
(Fig. 6). Analog A-C showed high affinity (ICs0: 8.2× 10 t[~ 
M) for the N-type calcium channel comparable to that of 
mMVIIA (IC~0: 4.0× 10 -1° M), while C-A showed very low 
affinity ( IC50:8.2×10 s M) like mMVIIC (IC,~0: 6 .5×10*  
M) (Fig. 6A). Therefore, the N-terminal half of mMVIIA 
folding / - -  f ' 
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Fig. 2. HPLC profiles of the oxidative folding reaction of chimeric analogs. The upper parts show the profiles of crude linear precursors, and 
the lower parts show those of the reaction mixture after 3 days. Large peaks at around 4 rain are due to the solvent, GSH, or GSSG. Column: 
Shim-pack CLC-ODS (4.6×250 mm, Shimadzu). Solvent: linear gradient from 5% to 35% CHaCN in 0.1% TFA for 30 rain. Flow rate: 1 ml/ 
min. Monitoring: absorbance at 230 nm (intensity is not scaled). 
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seemed to contain all the residues essential for high affinity 
recognition of the N-type calcium channel. For the P/Q-type 
channel, both A-C ( ICs0:3 .2x10 -s M) and C-A (ICs0: 
3.3X 10 -7 M) showed weaker affinity than c0MVI1C (ICs0: 
3.0 X 10 -9 M) (Fig. 6B), suggesting that the essential residues 
for the interaction with P/Q-type channel are spread over the 
whole oJMVIIC molecule. 
4. Discussion 
For the structure-activity relationship study of peptides 
with multiple disulfide bonds, it is essential to confirm that 
the analogs have the same disulfide pairings as those of native 
peptide. Kubo et al. determined the mode of disulfide pairings 
of native toMVIIC by comparing its enzymatic digestion prod- 
ucts with two synthetic model peptides [7]. Although we did 
not synthesize these model peptides, comparison of enzymatic 
digestion products of the analogs to that of coMVIIC clearly 
showed that these peptides were identical to each other. Dur- 
ing second digestion with thermolysin, we unexpectedly ob- 
served a cleavage of the Argl°-Leu al bond in A-C as assigned 
from peak 2B with MH + 1270. Fortunately, this cleavage did 
not affect the identification of the mode of disulfide parings. 
In addition to the confirmation of conserved isulfide par- 
ings, CD spectra were measured to prove that the analogs 
have similar overall conformation to those of native c0-con- 
otoxins. Recently, we reported that the common profiles ob- 
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Fig. 3. HPLC profiles of the reaction solution of o~MVIIC, A-C, 
and C-A treated successively with lysyl endopeptidase and thermoly- 
sin. Analysis was carried out in the same condition as described in 
the legend for Fig. 2 except hat the linear gradient was from 1% to 
31% CH3CN in 0.1% TFA for 30 min. 
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Fig. 4. Structures of enzymatic digestion products of ¢0MVIIC, A-C, 
and C-A. 
served in the CD spectra of coMVIIC and coMVIIA reflected 
their conformational similarity such as triple-stranded anti- 
parallel [3-sheet stabilized by three intramolecular disulfide 
bonds [8]. The similarity of CD spectra of A-C and C-A to 
those of t~MVIIC and toMVIIA, respectively, suggested that 
their overall conformations were not significantly affected by 
amino acid substitutions. It is interesting that the chain length 
between the fifth and sixth Cys residues eems to reflect the 
difference in CD spectra. The fifth and sixth Cys residues are 
located in the second and the third [3-strand, respectively, and 
the residues between the fifth and sixth Cys residues connect 
these two [3-strands. The length of this hinge region may not 
affect the relative orientation of two [3-strands but may affect 
the CD spectral profiles. 
The three-dimensional structures of c0GVIA [9-12], 
toMVIIA [13-15], and coMVIIC [16,17] have been determined 
by NMR analysis. Despite differences in primary amino acid 
sequences, the polypeptide chain framework is conserved in 
all of the co-conotoxins. Thus the nature of the amino acid 
side chains may have a leading role in determining the toxin 
selectivity. In the present study, we have found that the essen- 
tial residues are largely different for selective binding to N- 
and P/Q-type calcium channels. 
Previously, we showed that Tyr 13 is essential for the activity 
of 0~GVIA and that Lys 2 is the second important residue 
based on the results of systematic single Ala substitution 
[18,19]. Because replacement of other residues by Ala did 
not affect the binding, we proposed a two-point binding mod- 
el between toGVIA and the N-type calcium channel [19]. In 
the case of coMVIIA, replacement of Tyr 13 by Ala also re- 
sulted in a significant loss of affinity, whereas ubstitution of 
Lys 2 did not affect the binding [20]. Loss of the basic side 
chain of Lys 2 may be compensated by other basic residues 
such as Lys 7 [13]. Nadasdi et al. also reported that the re- 
placement of Tyr 13 in toMVIIA by Phe reduced the affinity to 
0.5% of native coMVIIA and that the elimination of some 
positive charges also affected the binding [21]. These previous 
observations agree with the present results demonstrating that 
a limited number of residues are important for the binding of 
coMVIIA to N-type calcium channels. Although the sequence 
of chimeric analog A-C is almost he same as that of coMVIIC 
except for four residues in the N-terminal half (Fig. 1), its 
affinity for N-type channels is almost the same as that of 
~oMVIIA and 100 times higher than that of coMVIIC. This 
result indicates that some of these four residues, which are 
located around the Tyr 1~ residue in a three-dimensional struc- 
ture, are essential for the recognition of N-type calcium chan- 
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Fig. 5. CD spectra of (oMVIIA, coMVIIC, and their chimeric analogs in H.20 solution (0.0l M sodium phosphate, pH 7.0) at 20°C. 
nels. We are currently studying the mechanism of selective 
binding to N-type channels by replacing these four residues 
in several combinations. 
On the other hand, results with chimeric analogs uggested 
that essential residues for the P/Q-type channel recognition 
are widely spread over the 0)MVIIC molecule. Previously we 
reported that the replacement of Tyr 1:~ in (0MVIIC by Ala 
significantly reduced the affinity, suggesting that Tyr ~ is a 
common binding motif in (o-conotoxins irrespective of the 
calcium channel subtypes that they target [5]. In order to 
identify the residues essential for subtype recognition, system- 
atic Ala scanning for e0MVIIC is also currently in progress. 
Voltage-gated calcium channels are complex membrane 
proteins consisting of multiple subunits [1 3]. A central chan- 
nel pore is formed by an cq subunit hat has four motifs, I 
IV, each having six transmembrane segments, S1 $6. A pore- 
lining segment H5 between segments 5 ($5) and 6 ($6) is 
thought o be essential for the ion selectivity. The (~1 subunits 
of N- and P/Q-type calcium channels have been cloned and 
designated aln and cqA, respectively, according to the nomen- 
clature of voltage-gated calcium channels [22]. The amino acid 
sequences of H5 segments are almost identical between N- 
and P/Q-type calcium channels [23,24]. Cloning, mutagenesis 
and expression of cq subunits howed that the most dramatic 
effects on the interaction between ~0GVIA and N-type calcium 
channel involved a single cluster of residues in the large pu- 
tative extracellular loop between IIIS5 and IIIH5, consistent 
with a direct pore-blocking mechanism [25]. A combination of
mutational studies on both ion channels and their specific 
blockers will provide knowledge of the architecture of the 
outer vestibules of the channel pores. The selectivity of 
c0MVIIC to the P/Q-type channels is not complete, since it 
still retains weak affinity with the N-type calcium channel 
(Fig. 6A). Furthermore specific blockers are not yet available 
for T-type calcium channels or channels coded by the class E 
(alV,) genes. In combination with the comparison of amino 
acid sequences of H5 segments of calcium channels, study of 
the blocking mechanism of eo-conotoxins may enable the de- 
sign and synthesis of novel blockers with appropriate specific- 
ities. 
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